Your response has been recorded.

Which result would most change care over the next two years?

• Clearer evidence on when sirolimus balloons outperform other restenosis options
• Durable FOP outcomes with Atebrioz beyond the initial study
• Human data showing whether PM647 safely corrects its target
• Measurable reductions in treatment delays from medication-access AI